🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦

NR 511 Week 3 SNAPPS Written Assignment; Managing Low Libido & Mood in Menopause

Chamberlain University Nursing NR 511 Differential Diagnosis and Primary Care Practicum Pete Flaherty 3 pages
View Full Course

Document Preview

Unlock Full 3 Page Document Instantly.

Document Overview

supplements and over-the-counter treatments have not consistently shown benefits in high- quality trials, but cognitive behavioral therapy (CBT), when customized for menopausal women, has shown efficacy in reducing mood and even mild sexual dysfunction in addition to pharmaceutical interventions (Voedisch, 2025). In order to apply non-hormonal management strategies for menopausal women with mood disorders and low libido, a nurse practitioner must conduct a thorough assessment of symptoms, provide evidence-based treatments for mood and sexual dysfunction, such as cognitive behavioral therapy or SSRIs/SNRIs, and educate patients about non-prescription lubricants and lifestyle changes that can promote psychological and sexual health (Huang et al., 2025). This method prioritizes continuous monitoring for efficacy and side effects using the most recent research and current best-practice recommendations, promotes shared decision-making regarding treatment alternatives, and guarantees patient autonomy and safety for those who are unable or unable to take hormone therapy. The FDA-approved non-hormonal medication flibanserin (Addyi) is available for some premenopausal women with hypoactive sexual desire disorder (HSDD), but it is not recommended for postmenopausal women(Witten et al., 2024). Topical non-hormonal vaginal moisturizers/lubricants are frequently advised for vaginal dryness, and other non-hormonal pharmacologic alternatives, including gabapentin (for vasomotor symptoms) and clonidine (for night sweats) may be utilized.

Full content available after purchase or with an active subscription.

Related Products

Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.